Century Therapeutics, Inc. Common Stock
Symbol: IPSC (NASDAQ)
Company Description:
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
- Today's Open: $0.505
- Today's High: $0.505
- Today's Low: $0.501
- Today's Volume: 7.57K
- Yesterday Close: $0.5077
- Yesterday High: $0.5171
- Yesterday Low: $0.494
- Yesterday Volume: 539.44K
- Last Min Volume: 7.50K
- Last Min High: $0.504
- Last Min Low: $0.501
- Last Min VWAP: $0.504
- Name: Century Therapeutics, Inc. Common Stock
- Website: https://www.centurytx.com
- Listed Date: 2021-06-18
- Location: PHILADELPHIA, PA
- Market Status: Active
- CIK Number: 0001850119
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $43.86M
- Round Lot: 100
- Outstanding Shares: 86.39M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-10 | 4 | View |
2025-09-10 | 4 | View |
2025-09-10 | 4 | View |
2025-09-08 | 144 | View |
2025-09-08 | 144 | View |
2025-08-29 | 8-K | View |
2025-08-18 | 144 | View |
2025-08-18 | 4 | View |
2025-08-14 | 10-Q | View |
2025-08-14 | 8-K | View |
2025-08-06 | 4 | View |
2025-07-10 | S-3 | View |
2025-07-07 | 8-K | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |
2025-06-16 | 4 | View |